Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Cancer Metastasis Reviews|July 11, 2023
Short-chain fatty acids in cancer pathogenesisMark A Feitelson, Alla Arzumanyan, Arvin Medhat, et al.Biomedicines|September 23, 2022
Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis BMark A Feitelson, Alla Arzumanyan, Ira Spector, et al.Oncotarget|December 2, 2021
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinomaArvin Medhat, Alla Arzumanyan, Mark A FeitelsonExpert Opinion on Therapeutic Targets|January 7, 2014
The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver diseaseMark A Feitelson, Barbara Bonamassa, Alla ArzumanyanNature Reviews. Cancer|January 25, 2013
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinomaAlla Arzumanyan, Helena M G P V Reis, Mark A FeitelsonCancer Research|April 6, 2011
Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?Alla Arzumanyan, Tiffany Friedman, Irene O L Ng, et al.Antimicrobial Agents and Chemotherapy|September 19, 2012
Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replicationRaymond F Schinazi, Leda Bassit, Marcia M Clayton, et al.Cancer Research|September 19, 2012
Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X proteinAlla Arzumanyan, Vaishnavi Sambandam, Marcia M Clayton, et al.Plos One|October 25, 2012
A spiroligomer α-helix mimic that binds HDM2, penetrates human cells and stabilizes HDM2 in cell cultureZachary Z Brown, Kavitha Akula, Alla Arzumanyan, et al.Viruses|January 20, 2021
Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly ModulatorSelwyn J Hurwitz, Noreen McBrearty, Alla Arzumanyan, et al.Pageof 6